J
J. S. Andersen
Researcher at University of Texas Health Science Center at San Antonio
Publications - 2
Citations - 6096
J. S. Andersen is an academic researcher from University of Texas Health Science Center at San Antonio. The author has contributed to research in topics: Gemcitabine & Randomized controlled trial. The author has an hindex of 2, co-authored 2 publications receiving 5812 citations.
Papers
More filters
Journal ArticleDOI
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
H. A. Burris,Malcolm J. Moore,J. S. Andersen,M R Green,Mace L. Rothenberg,M R Modiano,M. C. Cripps,Russell K. Portenoy,A M Storniolo,P Tarassoff,R Nelson,F A Dorr,C. D. Stephens,D. D. Von Hoff +13 more
TL;DR: It is demonstrated that gemcitabine is more effective than 5-FU in alleviation of some disease-related symptoms in patients with advanced, symptomatic pancreas cancer and confers a modest survival advantage over treatment with5-FU.
Journal ArticleDOI
A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer
M. L. Rothenberg,Malcolm J. Moore,M. C. Cripps,J. S. Andersen,Russell K. Portenoy,H. A. Burriss,Mark R. Green,Peter Tarassoff,T. D. Brown,Ephraim S. Casper,Anna Maria Storniolo,D. D. Von Hoff +11 more
TL;DR: It is suggested that gemcitabine is a useful palliative agent in patients with 5-FU-refractory pancreas cancer and systematic assessment of subjective outcomes can be used to evaluate the clinical impact of new therapies for pancrea cancer, a highly symptomatic disease.